SciBase EIS Tech Named Primary Endpoint in NIH THREAT Skin Study
Stockholm – October 15, 2026 -- The US National Institutes of Health (NIH) has selected SciBase Holding AB's Nevisense electrical impedance spectroscopy (EIS) technology as the primary endpoint in its THREAT study, which will test how environmental exposures affect the skin barrier in 80 healthy volunteers.
NIH and Swiss institute launch THREAT study on everyday exposures
THREAT (Testing Harms Related to Exposure to Allergenic Toxins) is led by the NIH in collaboration with the Swiss Institute of Allergy and Asthma Research (SIAF). The study design is described in an editorial in the peer-reviewed journal Allergy, titled "Exploring the Link Between Environmental Exposures and Disease via Direct Challenge."